04.18.97

Page 1

t eanc 0 VOL. 41, NO. 16 •

Friday, April 18, 1997

FALL RIVER DIOCESAN NEWSPAPER FOR SOUTHEAST MASSACHUSEnS CAPE COD & THE ISLANDS

FALL RIVER, MASS.

Southeastern Massachusetts' Largest Weekly

•

514 Per Year

Manufacturer yields patent rights to another producer

U.S. boycott forces European, companies to abandon RU-486 WASHINGTON (CNS) - The U.S. bishops' pro-life spokeswoman lauded a decision by the European makers of the abortion drug, RU- 486, to stop manufacturing, marketing and distributing the controversial drug. "This is due to the efforts of so many pro-life groups which have ceaselessly spoken about the threats this drug poses to women and children," said HelenAlvare, director of planning and information for the U.S. bishops' Secretariat for Pro-Life Activities, in a recent statement in Washington. In announcements a day earlier in Paris and Frankfurt, Germany, Roussel Uelaf, the French developer and manufacturer of RU-486, and Roussel's German parent, Hoechst AG, conced,ed that a U.S. boycott by pro-life groups contributed 'to the decision to transfer patent rights and dissociate the companies from RU-486. "Roussel Uclaf no longer has the means to be able to withstand the boycott threats," said Hoechst spokeswoman Catherine Euvrard in Paris, according to an Associated Press report. "This product can no longer be part of the strategy of an international ," company." She said the risk of losing $1.63 billion in U.S. business was not worth annual European sales of RU-486 totaling $3.5 millio,n. So, at no cost, the European companies gave patent rights outside the United States to Dr. Edouard Sakiz, one of the drug's creators who until recently was supervisory board chairman of Roussel Uelaf. U.S. patent rights were transferred in 1994 to The Population Council, a nonprofit organization in New York City. It was in 1994 that the National Right to Life Committee and other pro-life, profamily groups began a boycott of products made by U.S. subsidiaries of Roussel Uelaf and Hoechst AG. NRLC officials have said the purpose of the boycott was to stop the manufacture of RU-486, the first of two pills taken, in a drug regimen for terminating early pregnancies. NRLC responded to news of the patent transfer by urging the European companies to revoke all agreements that allow anyone to make the drug. In a statement issued April 8 in Washington, NRLC called on Roussel and Hoechst "to pull RU-486 from the U.S. market by rescinding the patent rights granted to The Population Council." NRLC also urged the European supplier "not qnly to cease its own manufacture of RU-486 in Europe but also to rescind the agreement with Edouard Sakiz and not to grant the manufacturing rights to anyone to produce this death pill." In her statement, Alvare said she was dismayed that Hoechst had dissociated itself only financially, "and will freely give its patent to an enthusiast for the drug," who could produce and market RU-486 "in countries where Hoechst had previpusly refused:' ' "Hoechst ought to have repudiated the drug entirely," she said. . , , Just a week before the transfer was revealed, boycott organizers in Washington increased pressure on the European companies by announcing a campaign targeting Allegra, the new antihistamine from Hoechst Marion Roussel, a U.S. subsidiary of, , ' , ' :" " Roussel Uelaf and Hoechst AG. ' Full-page newspaper ads asking consumers to forgo Allegra appeared April 2 in U.S. and international editions of USA Today and were to appear in other publications. The ad urged consumers to "help stop RU-486" by joining theboycptt:a~ainst , Hoechst Marion Roussel. '" ', ' Boycott organizers said then they believed the boycott was having an effect-.NRLC executive director David O'Steen said "hundreds of thousands" of boycott postcards had been returned to NRLC and to the drug companies.' Currently, RU-486 is available in Europe but only in France, Britain and, S\yeden. The Food and Drug Administration approved RU- 486 for sale in .the Uti~ted States last September, but it is not yet available. , ' , . "; " In Paris, new patent-holder Sakizsaid April She wo~ld distribute the dJ:ug only to countries that foIlowed strict guidelines for its use, a requirement thought -to exclude most developing countries and Russia.. ' , ' He also said the new company he is ofotming to takeover all manufacluring, marketing and distributing of RU~86 outside the United States would not be working with The Population Council. ', , ' " In its April S statement, NRLC renewed an appeal that "Hoechst AG should make public the terms of the agreement between The Populati<?n Council andRo'ussel Uclaf:' ' Since the agreement was never made pU,blic, NRLC argued, "there may be provisions ... that give Roussel Uclaf and Hoechst AG some say in the development of ' RU-486 in the United States."

, j

~"':

.

POPE JOHN PAUL II kisses a Bosnian girl during an outdoor Mass at Sarajevo's Kosevo stadium April 13. Some 50,000 people packed the sports arena and heard the pope's plea for forgiveness and peace in Bosnia. (eNS/ Reuters photo)

Pope visits war-torn Sarajevo

Visit brings hope to a land that has had little By John Thavis SARAJEVO, Bosnia-Herzegovina (eNS) - In an intense, his,toric visit to war-shattered Sarajevo, Pope John Paul II beseeched rival ethnic groups to find forgiveness in their hearts and a peace that goes deeper than political accords. "The time has come to resume a sincere dialogue of brotherhood, accepting and offering forgiveness: The time has come to overcome the hatred and vengeance which still hinder the re-establishment of genuine peace in Bosnia-Herzegovina," the pope said April 13 at a meeting with Muslim representatives. Turn to Page' 13


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.